Publication | Closed Access

In vivo antigen challenge in celiac disease identifies a single transglutaminase-modified peptide as the dominant A-gliadin T-cell epitope

Autoimmune DiseaseCeliac DiseaseImmunologyImmune RegulationPathologyImmunodominanceAntigen ProcessingAutoimmunitySingle Transglutaminase-modified PeptideImmunotherapyMedicineVivo Antigen Challenge